TRPC1 and breast carcinoma: Knockdown of ORAI1 had no effect on constitutive ERK1/2 activity in these cells; however, silencing of TRPC1 channels led to a pronounced reduction in constitutively active ERK1/2 in MDA-MB-468 breast cancer cells (Fig. 8A & B).